These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2455354)

  • 21. Sequential observations of in vitro responses of lymphocytes to phytohemagglutinin in patients receiving gold therapy for rheumatoid arthritis.
    Percy JS; Davis P; Miller CL; Russell AS
    J Rheumatol Suppl; 1979; 5():117-9. PubMed ID: 114640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gold therapy of rheumatic diseases].
    Berndt H
    Z Arztl Fortbild (Jena); 1987; 81(9):416. PubMed ID: 3114970
    [No Abstract]   [Full Text] [Related]  

  • 23. The activity of natural killer cells in patients with rheumatoid arthritis: I. The effect of drugs used in vivo.
    Russell AS; Miller C
    Clin Exp Rheumatol; 1984; 2(3):227-9. PubMed ID: 6442225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The detection of gold atoms in lymphocyte and erythrocyte chromatin following therapy with 2 different gold compounds in patients with chronic polyarthritis].
    Bröll H; Tausch G; Teherani DK
    Wien Klin Wochenschr Suppl; 1984; 156():16. PubMed ID: 6442049
    [No Abstract]   [Full Text] [Related]  

  • 25. Gold in rheumatoid arthritis; the past, present and future. Proceedings of a symposium held in Copenhagen, April 15-16, 1983.
    Scand J Rheumatol Suppl; 1983; 51():1-139. PubMed ID: 6426042
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of colloid gold in the treatment of rheumatoid arthritis].
    Popović M; Davis P
    Vojnosanit Pregl; 1978; 35(4):284-9. PubMed ID: 100966
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunosuppressive actions of gold salts.
    Petersen J; Bendtzen K
    Scand J Rheumatol Suppl; 1983; 51():28-35. PubMed ID: 6426050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheumatoid arthritis V: therapy with remission-inducing agents.
    Gaines LM
    Md State Med J; 1982 Sep; 31(9):49-50. PubMed ID: 6815385
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of lymphocyte subpopulations using monoclonal antibodies in patients with rheumatoid arthritis undergoing treatment with a new gold salt (auranofin)].
    Di Matteo L; D'Incecco V; Evangelista L; Castiglione C; Consoli G
    Boll Soc Ital Biol Sper; 1985 May; 61(5):777-81. PubMed ID: 3927943
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
    Harth M; McCain GA; Orange JF
    J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of patients with rheumatoid arthritis with DMARD (disease modifying anti-rheumatic drugs)].
    Halberg P
    Ugeskr Laeger; 1984 Jul; 146(27):1995-2000. PubMed ID: 6440327
    [No Abstract]   [Full Text] [Related]  

  • 32. The immunological consequences of gold therapy: a prospective study in patients with rheumatoid arthritis.
    Hassan J; Hanly J; Bresnihan B; Feighery C; Whelan CA
    Clin Exp Immunol; 1986 Mar; 63(3):614-20. PubMed ID: 3086003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term comparative studies on gold, D-penicillamine, and NSAIDs for the treatment of early rheumatoid arthritis. 1. Evaluation of one year's treatment].
    Azuma T; Sugawara S; Maeda A; Miyauchi T; Aritomi H
    Ryumachi; 1986 Jun; 26(3):200-9. PubMed ID: 3097838
    [No Abstract]   [Full Text] [Related]  

  • 34. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
    Simon LS
    Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. II. Unbound versus total serum gold concentration: pharmacological actions on cellular function.
    Lorber A; Kunishima DH; Harralson AF; Simon TM
    J Rheumatol; 1983 Aug; 10(4):568-73. PubMed ID: 6413684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E
    Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J; Davis P; Owen ET
    J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.
    Domljan Z; Borso G; Marinković M; Winter Fudurić I; Pucar I; Cikes N
    Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058
    [No Abstract]   [Full Text] [Related]  

  • 39. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gold in the dermis following gold therapy for rheumatoid arthritis.
    Cox AJ; Marich KW
    Arch Dermatol; 1973 Nov; 108(5):655-7. PubMed ID: 4201477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.